Type 2 Diabetes Triggered by Overspill of Fat from Liver into Pancreas
Research confirms that Type 2 diabetes is caused by excess fat within both the liver and pancreas.
Related Articles
First Arab Human Pangenome Sequenced
The UAE Pangenome Reference is freely available to support research into genetic disorders, disease predisposition, and population health.
TF Binding Mapped via DynaTag in Single Cells, Low-Input Samples
A new physiological salt-based method enables high-resolution transcription factor mapping in small and single-cell samples.
GeneAgent Reduces AI Hallucinations in Gene Function Prediction
The AI model, GeneAgent, reduces hallucinations for gene-set analysis by autonomously interacting with biology databases to verify output.
Stuttering’s Genomic Signature Identifies 57 Loci and Links to Autism, Depression, and Musical Rhythm
Large-scale study defines genetic architecture of stuttering; findings point to 48 genes associated and highlight neurological risk pathways.
Sarepta to Resume Shipping DMD Gene Therapy to Ambulant Patients
Sarepta Therapeutics said it will resume shipments of its gene therapy Elevidys® (delandistrogene moxeparvovec-rokl) “imminently” to ambulant patients with Duchenne muscular dystrophy (DMD), ending a…
StockWatch: Abivax Shares Leap on Phase III Ulcerative Colitis Data, $747.5M Offering
Abivax dazzled investors and analysts with positive data from a pair of Phase III induction trials assessing obefazimod in adults with moderately to severely active…
Mitophagy Mechanism Unlocks Therapy Path for Parkinson’s Disease
The molecular rules underlying autophagy of mitochondria, or mitophagy, provide therapeutic applications for neurodegeerative disease.
Cell Activity Predicted Using Plain-Language “Hypothesis Grammar”
Method combines genomics technologies with computational modeling to predict changes in multicellular behavior, such as cell communication.
Mass Administration of Ivermectin Slows Malaria Transmission in Kenya
Ivermectin is an effective strategy to control malaria transmission, according to a trial in Kenya, which showed a 26% reduction in new infections.
FDA Probes Death of Brazilian Boy Linked to Sarepta’s Elevidys
The FDA is investigating the death last month of an eight-year-old boy in Brazil who had received Sarepta Therapeutics’ Elevidys® (delandistrogene moxeparvovec-rokl)—though the company and…